Deal Making

Featured on Deal Making

ElevateBio adds genome engineering tech with Life Edit buy
Deal-Making
ElevateBio adds genome engineering tech with Life Edit buyElevateBio adds genome engineering tech with Life Edit buy

Life Edit’s genome editing capabilities will be combined with ElevateBio’s CGT enabling tech to expand the number of therapeutic uses.

byMillie Nelson, Editor
Nov 1, 2021
|
2 Min Read
Ecolab to acquire Purolite in $3.7bn deal
Deal-Making
Ecolab to acquire Purolite in $3.7bn dealEcolab to acquire Purolite in $3.7bn deal
byMillie Nelson
Nov 1, 2021
2 Min Read
Autolomous and Vineti partner to deliver end-to-end solutions in CGT space
Deal-Making
Autolomous and Vineti partner to deliver end-to-end solutions in CGT spaceAutolomous and Vineti partner to deliver end-to-end solutions in CGT space
byMillie Nelson
Oct 28, 2021
3 Min Read
BioNTech eyes mid-2022 to build mRNA facility in Africa
Facilities & Capacity
BioNTech eyes mid-2022 to build mRNA facility in AfricaBioNTech eyes mid-2022 to build mRNA facility in Africa
byMillie Nelson
Oct 27, 2021
2 Min Read
NorthX Biologics takes over Charles River Swedish plant
Facilities & Capacity
NorthX Biologics takes over Charles River Swedish plantNorthX Biologics takes over Charles River Swedish plant
byMillie Nelson
Oct 25, 2021
2 Min Read
Joint research agreement to develop viral vector tech, says Matica Bio
Deal-Making
Joint research agreement to develop viral vector tech, says Matica BioJoint research agreement to develop viral vector tech, says Matica Bio
byMillie Nelson
Oct 25, 2021
2 Min Read

More from Deal Making

Hansoh goes for GOLD in siRNA partnership
Deal-Making
Hansoh goes for GOLD in siRNA partnership
Hansoh goes for GOLD in siRNA partnership
Oct 22, 2021
|
1 Min Read
byMillie Nelson, Editor
ISCT partners to provide ‘urgent’ training programs for CGT workforce
Deal-Making
ISCT partners to provide ‘urgent’ training programs for CGT workforce
ISCT partners to provide ‘urgent’ training programs for CGT workforce
Oct 21, 2021
|
2 Min Read
byMillie Nelson, Editor
Terumo and BioCentriq to drive automated CGT manufacturing
Deal-Making
Terumo and BioCentriq to drive automated CGT manufacturing
Terumo and BioCentriq to drive automated CGT manufacturing
Oct 20, 2021
|
2 Min Read
byMillie Nelson, Editor
Aceto buffers up presence in bioprocessing with A&C buy
Upstream & Downstream Processing
Aceto buffers up presence in bioprocessing with A&C buy
Aceto buffers up presence in bioprocessing with A&C buy
Oct 13, 2021
|
2 Min Read
byDan Stanton, Editorial director
Ins and outs: High level changes at BlueRock, Pfizer and the NIH
Deal-Making
Ins and outs: High level changes at BlueRock, Pfizer and the NIH
Ins and outs: High level changes at BlueRock, Pfizer and the NIH
Oct 13, 2021
|
3 Min Read
byMillie Nelson, Editor
Simulated Bed fellows: Tosoh buys purification firm Semba
Upstream & Downstream Processing
Simulated Bed fellows: Tosoh buys purification firm Semba
Simulated Bed fellows: Tosoh buys purification firm Semba
Oct 11, 2021
|
3 Min Read
byDan Stanton, Editorial director
ViroCell partnership to double UK lentivirus vector capacity
Deal-Making
ViroCell partnership to double UK lentivirus vector capacity
ViroCell partnership to double UK lentivirus vector capacity
Sep 30, 2021
|
2 Min Read
byMillie Nelson, Editor
Gamma invests in bio-sensor and analytics firm Nirrin
Upstream & Downstream Processing
Gamma invests in bio-sensor and analytics firm Nirrin
Gamma invests in bio-sensor and analytics firm Nirrin
Sep 28, 2021
|
2 Min Read
byDan Stanton, Editorial director
Boston Labs and Germfree launch mobile CGT platform
Deal-Making
Boston Labs and Germfree launch mobile CGT platform
Boston Labs and Germfree launch mobile CGT platform
Sep 27, 2021
|
2 Min Read
byMillie Nelson, Editor
Novartis boosts optogenetics portfolio with Arctos buy
Deal-Making
Novartis boosts optogenetics portfolio with Arctos buy
Novartis boosts optogenetics portfolio with Arctos buy
Sep 27, 2021
|
2 Min Read
byMillie Nelson, Editor
Serum Institute invests $68m in Oxford Biomedica to expand vector capacity
Facilities & Capacity
Serum Institute invests $68m in Oxford Biomedica to expand vector capacity
Serum Institute invests $68m in Oxford Biomedica to expand vector capacity
Sep 22, 2021
|
2 Min Read
byDan Stanton, Editorial director
Moderna and AbCellera join forces to develop antibody therapies
Deal-Making
Moderna and AbCellera join forces to develop antibody therapies
Moderna and AbCellera join forces to develop antibody therapies
Sep 20, 2021
|
2 Min Read
byMillie Nelson, Editor
Biocon jumps into vaccines through $4.9bn Serum Institute pact
Global Markets
Biocon jumps into vaccines through $4.9bn Serum Institute pact
Biocon jumps into vaccines through $4.9bn Serum Institute pact
Sep 20, 2021
|
2 Min Read
byDan Stanton, Editorial director
CEVEC and UCB ink AAV manufacturing agreement
Deal-Making
CEVEC and UCB ink AAV manufacturing agreement
CEVEC and UCB ink AAV manufacturing agreement
Sep 17, 2021
|
1 Min Read
byMillie Nelson, Editor
Protein boost for Repligen through $150m Avitide buy
Upstream & Downstream Processing
Protein boost for Repligen through $150m Avitide buy
Protein boost for Repligen through $150m Avitide buy
Sep 17, 2021
|
2 Min Read
byDan Stanton, Editorial director
CureVac drops CDMOs but continues COVID-19 vaccine development
Deal-Making
CureVac drops CDMOs but continues COVID-19 vaccine development
CureVac drops CDMOs but continues COVID-19 vaccine development
Sep 15, 2021
|
2 Min Read
byMillie Nelson, Editor
Affinia strikes strategic AAV manufacturing deal with Lonza
Deal-Making
Affinia strikes strategic AAV manufacturing deal with Lonza
Affinia strikes strategic AAV manufacturing deal with Lonza
Sep 14, 2021
|
2 Min Read
byMillie Nelson, Editor
Ins & Outs: Genezen new CEO to lead transition into full service CDMO
Deal-Making
Ins & Outs: Genezen new CEO to lead transition into full service CDMO
Ins & Outs: Genezen new CEO to lead transition into full service CDMO
Sep 14, 2021
|
3 Min Read
byMillie Nelson, Editor
Sandoz expands biosimilar pipeline in Bio-Thera collaboration
Deal-Making
Sandoz expands biosimilar pipeline in Bio-Thera collaboration
Sandoz expands biosimilar pipeline in Bio-Thera collaboration
Sep 13, 2021
|
2 Min Read
byMillie Nelson, Editor
Moderna to develop mRNA therapeutic for ultra-rare disease
Deal-Making
Moderna to develop mRNA therapeutic for ultra-rare disease
Moderna to develop mRNA therapeutic for ultra-rare disease
Sep 9, 2021
|
2 Min Read
byMillie Nelson, Editor
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Deal-Making
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Sep 9, 2021
|
2 Min Read
byMillie Nelson, Editor
Avantor upping its single-use game in $2.9bn Masterflex buy
Upstream & Downstream Processing
Avantor upping its single-use game in $2.9bn Masterflex buy
Avantor upping its single-use game in $2.9bn Masterflex buy
Sep 8, 2021
|
1 Min Read
byDan Stanton, Editorial director
BioLife bolsters CGT portfolio through Sexton acquisition
Deal-Making
BioLife bolsters CGT portfolio through Sexton acquisition
BioLife bolsters CGT portfolio through Sexton acquisition
Sep 7, 2021
|
2 Min Read
byMillie Nelson, Editor
PE firm 3i to create injectable CDMO ten23 health
Deal-Making
PE firm 3i to create injectable CDMO ten23 health
PE firm 3i to create injectable CDMO ten23 health
Sep 6, 2021
|
2 Min Read
byMillie Nelson, Editor
Terumo and PhotonPharma partner to develop cancer vaccine
Deal-Making
Terumo and PhotonPharma partner to develop cancer vaccine
Terumo and PhotonPharma partner to develop cancer vaccine
Aug 27, 2021
|
2 Min Read
byMillie Nelson, Editor
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Deal-Making
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Aug 25, 2021
|
2 Min Read
byMillie Nelson, Editor
Pfizer to acquire Trillium in $2.3bn deal
Deal-Making
Pfizer to acquire Trillium in $2.3bn deal
Pfizer to acquire Trillium in $2.3bn deal
Aug 25, 2021
|
2 Min Read
byMillie Nelson, Editor
M&A rife in manufacturing space, driven by big CDMOs and PE
Deal-Making
M&A rife in manufacturing space, driven by big CDMOs and PE
M&A rife in manufacturing space, driven by big CDMOs and PE
Aug 19, 2021
|
4 Min Read
byDan Stanton, Editorial director
Moderna inks deal to build mRNA facility in Canada
Facilities & Capacity
Moderna inks deal to build mRNA facility in Canada
Moderna inks deal to build mRNA facility in Canada
Aug 13, 2021
|
1 Min Read
byMillie Nelson, Editor
MaxCyte to support Sana’s ex vivo cell therapy plans
Deal-Making
MaxCyte to support Sana’s ex vivo cell therapy plans
MaxCyte to support Sana’s ex vivo cell therapy plans
Aug 12, 2021
|
2 Min Read
byMillie Nelson, Editor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe